Literature DB >> 5395479

Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside.

H W Moser, A L Prensky, H J Wolfe, N P Rosman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5395479     DOI： 10.1016/0002-9343(69)90202-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

Review 1.  Farber disease: an ultrastructural study. Report of a case and review of the literature.

Authors:  L Zappatini-Tommasi; C Dumontel; P Guibaud; C Girod
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  A specific ultrastructural marker for disseminated lipogranulomatosis (Faber).

Authors:  C Schmoeckel; M Hohlfed
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

3.  Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

Authors:  Jakub Sikora; Shaalee Dworski; E Ellen Jones; Mustafa A Kamani; Matthew C Micsenyi; Tomo Sawada; Pauline Le Faouder; Justine Bertrand-Michel; Aude Dupuy; Christopher K Dunn; Ingrid Cong Yang Xuan; Josefina Casas; Gemma Fabrias; David R Hampson; Thierry Levade; Richard R Drake; Jeffrey A Medin; Steven U Walkley
Journal:  Am J Pathol       Date:  2017-04       Impact factor: 4.307

4.  Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.

Authors:  J Tohyama; Y Oya; T Ezoe; M T Vanier; H Nakayasu; N Fujita; K Suzuki
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

5.  Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.

Authors:  M Sugita; P Connolly; J T Dulaney; H W Moser
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

6.  Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.

Authors:  Fabian P S Yu; Diana Islam; Jakub Sikora; Shaalee Dworski; Jiří Gurka; Lucía López-Vásquez; Mingyao Liu; Wolfgang M Kuebler; Thierry Levade; Haibo Zhang; Jeffrey A Medin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-22       Impact factor: 5.464

7.  Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.

Authors:  Fabian P S Yu; Benjamin S Sajdak; Jakub Sikora; Alexander E Salmon; Murtaza S Nagree; Jiří Gurka; Iris S Kassem; Daniel M Lipinski; Joseph Carroll; Jeffrey A Medin
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

8.  Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.

Authors:  T Momoi; Y Ben-Yoseph; H L Nadler
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

9.  A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.

Authors:  U Burck; H W Moser; H H Goebel; R Grüttner; K R Held
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

10.  Light- and electron-microscopic histochemistry of Fabry's disease.

Authors:  T Faraggiana; J Churg; E Grishman; L Strauss; A Prado; D F Bishop; E Schuchman; R J Desnick
Journal:  Am J Pathol       Date:  1981-05       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.